Trial intelligence / Profile preview

Sublingual misoprostol with pericervical tourniquet versus placebo with pericervical tourniquet during abdominal myomectomy

PACTR202103517062817Completed

Sponsor
Adebayo M.D. Agboola
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in Fibromyoma (LM) comparing Misoprostol with pericervical tourniquet with Placebo with pericervical tourniquet (2 arms). Primary endpoint: Blood loss at abdominal myomectomy. Started Apr 2019; status: completed.

02

Drugs

misoprostol
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on PACTR202103517062817.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202103517062817.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call